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1. Introduction 
In daily clinical practise we frequently encounter situations in which the bone volume is 
insufficient for an ideal dental implant placement. Bone regeneration can provide the 
structural support necessary in these cases. Procedures such as sinus lifting and alveolar 
ridge augmentation have reached high levels of predictability and already are of major 
importance in implant practise. Interest for bone substitutes for alveolar ridge augmentation 
or preservation appears in the early 1980’s alongside the development of endoosseous 
dental implants. Although first studies regarding bone substitutes dates from 1920 by Albee 
(Albee, 1920), until 1980´s there are very few studies in reference this issue. From 1980´s 
until nowadays  an exponential number of studies about bone substitutes have been made.  
The reason for this increasing interest in bone substitutes stems from the fact that about 10-
20% of the patients that need treatments with dental implants, require bone regeneration 
procedures before implant placement. Moreover, more than 60% of the population in 
industrialized countries need dental prosthetic replacements (Peterson, 2006), ideally with 
implants. This is the reason why the market of dental implants is experiencing an increase of 
approximately 15% every year.  
Bone regeneration procedures are becoming an almost daily practice in dentistry all around 
the world as a result of the wide acceptance of dental implants as the “ideal” option for oral 
rehabilitation. Bone regeneration procedures are critical for the success of dental implant 
treatments in cases where there is a deficiency in bone width and/or height. The 
cornerstone in these treatments is the use of bone substitutes to create a bone mantle that 
covers the screw to enhance implant stability and treatment outcome. In this chapter, we 
will discuss the different types of bone substitutes and recent developments achieved to 
enhance the outcomes of bone regeneration procedures with the newest available 
biomaterials.  
The term “bone graft” was defined by Muschler (Bauer, 2000) as: “any implanted material 
that alone or in combination with other materials promotes a bone healing response by 
providing oteogenic, osteoinductive or osteoconductive properties”. An osteogenic material 
can be defined as one that has inherent capacity to form bone, which implies to contain 
living cells that are capable of differentiation into bone cells. An osteoinductive material 
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provides biologic signals capable to induce local cells to enter a pathway of differentiation 
leading to mature osteoblasts. An osteoconductive biomaterial provides a three-dimensional 
interconnected scaffold where local bone tissue may regenerate new living bone. However, 
osteoconductive biomaterials are unable to form bone or to induce its formation.  
Another property that is interesting to find especially in bone substitutes is biodegradability. 
This is defined as the capacity of degradation of a particle by two mechanisms principally; 
through a passive chemical degradation or dissolution, and through active cellular activity 
mediated by osteoclast and/or macrophages. Moreover, the biological properties of bone 
substitute biomaterials are also influenced by their porosity, surface geometry and surface 
chemistry. The events leading to bone healing and regeneration are influenced by all the 
variables mentioned above. These properties are related to the biomaterial itself, however, 
host factors such as bone quality, vascularity of the graft bed and tobacco addiction may 
also influence the final outcome of a bone regeneration procedure with a bone substitute.   
2. Biomaterials used for bone regeneration in implant dentistry  
Bone graft materials can be divided in four large groups: Autografts, Allografts, Xenografts 
and Synthetic biomaterials. 
2.1 Autograft 
“Autograft” refers to bone tissue harvested from, and implanted in the same individual. 
Accordingly, autograft is a bone tissue that is separated from one site and implanted in 
other location in the same individual. The cellular component of trabecular bone graft 
includes few osteoblasts and a high number of precursor cells that survive the 
transplantation. These precursor cells explain the osteogenic potential of bone autograft. 
Autograft is considered the “gold standard” in bone regeneration due to its properties of 
osteoconduction, osteoinduction, osteogenicity and osteointegration. However there are 
major drawbacks to the use of this sort of ideal bone graft, namely the necessity of a second 
surgery to retrieve the bone graft at the donor site, with its associated morbidity; the 
increasing surgery time, the restrictions in quantity and shape of the bone graft, and the 
additional cost (Arrington, 1996; Giannoudis, 2005). 
Autografts are subdivided in two groups: cancellous autografts and cortical autografts. 
Cancellous autografts are retrieved mainly from calcellous bone, and upon transaplantation, 
the majority of cells presnet in the grafts die as result of ischemia. However, the 
mesenchymal stem cells present in the bone marrow are resistant to ischemia and may 
survive the grafting procedure. The stem cells capacity of survival and proliferation after 
exposure to changes in the oxygen tension, pH and cytochine environment are the main 
reason behind the reliability of of cancellous bone autograft interventions. The incorporation 
of such type of autogrfraft is speed, about 8 weeks (Virolainen, 1995). 
Cortical autografts are segments of cortical bone composed of necrotic bone that provides an 
osteoconductive support for bone formation, but does not supply significant amounts of 
living cells. For this reason, revascularization and integration of cortical autografts is slow. 
The main advantage of cortical autografts is the mechanical support that provides at the 
graft site (Bauer & Muchler, 2000), while its incorporation is slower than cancellous 
autografts. 
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IM: Intramembranous bone, EC: Endochondral bone 
Table 1. Summary of bone autograft properties as a function of their anatomical origin    
2.2 Allografts: Freeze dried bone allograft (FDBA) and demineralized freeze dried 
bone allograft (DFDBA) 
Allograft is defined as tissue that has been harvested from one individual and implanted 
into another individual of the same species (Eppley, 2005).The use of cadaver bone for 
grafting is known as bone allograft and it is considered by some the best available 
alternative to autografts due its similarly characteristics. Despite the superior properties of 
autografts, allografts are usually preffered by patients as bone grafting material because 
they the problems associated to donor site surgery in autografts.. Allografts are obtained 
from cadaver tissue banks for mineralized freeze-dried (FDBA) or decalcified freeze-dried 
(DFDBA) bone.. Both FDBA and DFDBA are obtained from cortical bone of long bones due 
to its high content of bone inductive proteins and less antigenic activity than cancellous 
bone. Bone allografts come in various configurations, including powder, cortical chips, 
cancellous cubes, and cortical granules among others (Eppley, 2005). The granulated form is 
btained by milling the cortical bone under sterile conditions to obtain a particle size ranging 
from 250 to 750 m. Moreover, allografts  have been recently made available in different 
block forms; although their mechanical properties remains slightly lower than those of 
autograft cortical blocks.  
Once the allograft is harvested they  are processed through several methods including 
physical debridement to remove soft tissue and reduced cellular load, ultrasonic washing to 
remove remnant cells and blood, ethanol treatment in order to denaturalize proteins and 
viral deactivation, antibiotic wash to kill bacteria,  and sterilization through gamma 
radiation and  ethylene oxide for spore elimination (Khan, 2005). FDBA are washed in 
antibiotic twice for 1 hour, frozen at -70Cº and dried up to 5% of water (Kao, 2007).During 
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this process microfractures form along the allografts’ collagen fibers, resulting in a 
decreased in its  mechanical properties, for this reason it is  advised to rehydrate allografts 
before use to regain some of the lost properties (Kao, 2007).  Processed bone allografts do 
not include any living cells, and therefore, they lack osteogenic activity. Allografts are 
essentially osteoconductive, and depending how they are processes, they may have some 
osteoinductive properties (Stevenson, 1999). 
FDBA: Mineralized bone matrix has no active bone morphogenetic proteins (BMPs) and 
therefore it lacks osteoinductive properties, although it has osteoconductive properties. 
Graft incorporation is qualitatively similar to autograft, but occur more slowly. Cortical 
allografts will incorporate and eventually resemble their autograft counterpart although 
with more unremodeled necrotic bone present in allografts (Stevenson, 1999). Milled forms 
present an open structure that facilitate invasion by blood cells, enhance graft incorporation 
and allows mixing with blood, platelet concentrates and other graft materials forming 
composites. 
DFDBA: DFDBA forms are processed by acid demineralization in 0.5 to 0.6 molar 
hydrochloric acid as a result, 40% of the mineral content is removed leaving the organic 
matrix intact. This process preserves the BMPs present in bone, and therefore maintains 
some of the inherent osteoinductive properties (Khan, 2000). Moreover, the collagen matrix 
present in DFDBA acts as a scaffold that provides  osteoconductive properties alone side the 
osteoinductive behavior. Osteoinductivity of DFDBA was first described by Urist et al, after 
observing  endochondral bone formation on DFDBA when placed in soft tissue. It has since 
been discovered that BMPs are the factors responsible for the novo bone formation (Reddi, 
1998). BMPs are associated with the organic matrix of bone and embedded within mineral 
content, so demineralised process increases its bioavailability. BMPs attract mesenchymal 
stem cells and induce them to differentiate into chondrocytes leading into endochondral 
bone formation. Endochondral bone formation is attributed to a osteoinductivity response, 
while  intra-membranous bone formation is indicative of an osteoconductive response. 
Nevertheless, osteoinductivity of DFDBA has been recently questioned, since it seems that 
this property is highly dependent on the manufacturing procedures (Drosos, 2007) 
The main advantage of allografts include easy availability, avoiding the need of harvesting a 
patient donor site, reduced costs in terms of anesthesia (general anesthesia is not needed)  
and reduced surgical time. However, the use of cadaver bone for grafting is avoided by 
many clinicians due to its potential risk of infectious disease. Nevertheless, allografts have 
been used for more than 25 years without any reported incidence of disease transmission. 
The risk of HIV infection through allograft implantation has been  estimated to be 1 in 1.6 
million, compared with the risk of 1 in 450.000 in blood transfusions (Khan, 2000).  DFDBA 
forms may have even less risk of disease transmission than FDBA, because demineralization 
allows most affective removal of viruses and blood elements reducing immunological 
reactions (Eppley, 2005). Moreover the establishment of better equipped tissue banks has 
allowed an increase in the use of bone allografts, and there is a current tendency by many 
surgeons to replace autografts by bone allograft (Albert, 2006). 
Allografts are available in the form of granules and blocks. Allograft granules’ appearance is  
similar to other bone substitute granules, and they are ideal to fill bone cavities as alveolar 
bone defects and maxillary sinus. On the other hand, allograft blocks are especially useful in 
both vertical and horizontal bone augmentation procedures.  
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Table 2. Comparison between bone autograft and allograft according to their properties 
2.3 Xenografts: Anorganic bovine bone (ABB) 
Bone xenograft is defined a bone tissue harvested from one species and implanted into a 
different species. One of the most commonly used xenografts is anorganic bovine bone 
(ABB). ABB is a biomaterial with major long-term success reports in the bone regeneration 
literature and it has been extensively used in the clinics for over 20 years (Frame et al., 1987). 
ABB has an ultrastructural composition similar to human bone, it is composed of almost 
pure hydroxyapatite, and it is chemically treated to remove all organic components so it can  
be used as a graft material without causing host immune response (Mish et al., 1993). ABB is 
thermally and chemically treated in order to extract organic constituents and thereby 
eliminating its antigenicity and potential inflammatory response by the host bone (Cohen et 
al., 1994). The structure consists of a wide interconnective pore system with a particle size of  
0.25 to 1 mm  that can easily be invaded by blood vessels resulting in osteoblastic migration. 
. ABB is up to 75% porous and has a high specific surface area of almost 100 m2/g that 
results in increased angiogenesis, enhances new bone growth (Hammerle et al., 1997; 
Rodriguez, 2003), and excellent osteoconduction properties. However, its highly porous 
consistency sometimes compromises its mechanical properties and its initial stability. ABB 
lacks osteoinductive properties, and its presentation in form of granules makes it difficult to 
hold on surgical sites. Moreover, it is non resorbable in vivo.  Indeed, ABB might need 
several years (3-6 years) of implantation before showing some slow in vivo resorption 
through osteoclast activity, (Skoglung et al, reported that granules were present even after 
44 months (Skoglund., 1997) . The presence of unresorbed granules within the newly formed 
bone is undesired because it affects the quality of the newly formed bone by interfering with 
its remodelling, compromising its osteointegration capacity with dental implants.  
Although ABB is mostly used in form of  granules, xenografts blocks design  are also 
available. Xenogenic derived bone block have already been reported to achieve vertical bone 
augmentation in the mandible. However, these materials are quite brittle and fragile. This 
mechanical inconvenience not only complicates the surgical technique but it also hinders the 
bone graft healing process (Simion et al 2006; Felice et al., 2009). Other types of xenogenic 
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(porcine) bone block seems to show better mechanical properties and low risk of fracture 
while screwing. (Simion et al., 2009). Generally speaking, the use of xenogenic bone blocks is 
still under evaluation and at this moment there is not sufficient information regarding its in 
vivo behaviour. 
2.4 Synthetic calcium phosphates 
Calcium phosphates constitute synthetic biomaterials that chemically resemble the bone 
mineral . Calcium phosphate biomaterials are widely selected to regenerate bone tissue due 
to thier biocompatibility, osteointegration and osteoconductivity (Alkhraisat et al., 2008). We 
can make a classification of calcium phosphates in order to its Ca2+ and P compounds. 
 
   
Table 3. Summary of synthetic calcium phosphate bone substitutes arranged to their 
chemical composition and biological properties 
Regarding this classification is interesting to know that materials which contains high levels 
of Ca2+ ions have alkaline Ph and therefore shows low resorption capability as hidroxiapatite 
(AP), while materials with low levels of Ca2+ ions have acid Ph and shows high resorption 
properties, as dicalcium phosphate forms. 
According to their preparation, calcium phosphate could be divided into high temperature 
(ceramics of tricalcium phosphates, hydroxyapatite and biphasic calcium phosphate) and 
low temperature (cements) calcium phosphates. Such bone substitutes differ in the 
degradation rate in vivo, strength, alkalinity and acidity, and crystallographic structure. 
Generally, they are fragile materials and should be used in non-load bearing areas. 
Hydroxyapatite and ┚-tricalcium phosphate (┚-TCP) are the ceramics mostly recruited 
clinically to treat bone defects and voids. Biologicall, stoichiometric hydroxyapatite of Ca/P 
ratio of 1.67 is highly stable and its very slow degradation is mediated by phagocytosis 
[Constantino & Freidman, 1997). Such handicap is managed by introducing impurities like 
carbonate ions, silicon ions and other ionic species present in the bone mineral [Alkhraisat et 
al., 2008). Structurally, porous hydroxyapatite was introduced to resemble native bone 
architecture, improve the degradability and enhance tissue reaction of angiogenesis and 
new bone in-growth. This resulted in engineering apatite and calcium carbonate of live 
species to produce a hydroxypatite conserving the macro and microporous architecture of 
the source  . An example of such technology is the anorganic bovine bone, coral apatite and 
algae apatite.  
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Since the experiments reported by Albee and Morrison (Albee, 1920), research and 
development projects have been dedicated to explore the potential of ┚-TCP ceramic bone 
substitute. ┚-TCP has Ca/P ratio of 1.5 and is more resorbable than hydroxyapatite. This 
higher degradability is related to higher solubility that aid phagocytosis to induce 
biomaterial replacement with new bone.  
Biphasic calcium phosphate (BCP) is engineered to combine the advantages of both 
hydroxyapatite and ┚-TCP. A relation of 60% hydroxyapatite and 40% ┚-TCP is the most 
common among  commercial biphasic calcium phosphate.  
These ceramics are presented in porous granular and block forms and they are difficult to 
reshape. The granules have a size range between 0.2 mm and 1mm.    
The lack of adaptability of calcium phosphate ceramics was solved by Brown and co-
workers when they developed calcium phosphate cement (Brown & Chow, 1985). This 
cement is the mixture of calcium phosphate powders that upon reacting with aqueous phase 
produce new calcium phosphate. The chemical reaction that produce this new phase is 
termed setting reaction and the consistency of the cement is progressed from paste-like to 
solid structure by the entanglement of the setting product. This enable the cement to be 
moulded, adapt intimately to the bone defect borders and permits the development of 
injectable preparation for minimally invasive surgery. Such cements are biocompatable, 
degradable and osteoconductive (Figure 1) (Alkhraisat et al.,  2008). 
Calcium phosphate cements are classified according to the setting reaction end-product to 
hydroxyapatite and brushite cements. Hydroxyapatite cement is first developed by Brown 
and co-workers and since then variuos formulation have been developed and patented. Of 
such formulations are tetracalcium phosphate/dicalcium phosphate anhydrous (DCPA) 
system and ┙-TCP based system. The setting reaction of hydroxyapatite cement occurs at 
neutral pH which is biologically favourable. The hydroxyapatite as setting product is low-
crystalline and the stoichiometry can be varied to produce calcium deficient-hydroxyapatite 
(Ca/P ratio less than 1.67). These features and the development of carbonated apatite 
cement improve the degradability of hydroxyapatite cement.   
Since their development by Mirtchi and co-workers, brushite cements are recieveing much 
interest as bone substitute in the recent years [Mirtchi, 1990). These cements are obtained 
by various combinations, such as ┚-TCP + monocalcium phosphate monohydrate 
(MCPM) and ┚-TCP + phosphoric acid. The setting reaction of these cements is a 
continuous dissolution/precipitation mechanism at low pH values as brushite 
precipitates at pH <6 [Alkhraisat et al., 2010).. The relatively short setting time of brushite 
cements compared with hydroxyapatite forming pastes depends on both the higher 
solubility of the cement raw materials and the higher rate of brushite crystal growth (3.32 
× 10-4 mol min-1 m-2) [compared with hydroxyapatite (2.7×10-7 mol min-1 m-2) (Zawackiet 
al., 1996).  
The main advantage of brushite is its higher degradability compared to hydroxypatite that 
stems from higher solubility at physiological conditions. However, in vivo brushite 
transformation to hydroxyapatite is kinetically favourable and additives are patented to 
inhibit such transformation [Alkhraisat et al., 2010). This fact have raised the attention to the 
anhydrous form of brushite, monetite, that is prepared by drying brushite. Monetite is more 
stable than brushite due to its lower solubility and in vivo transformation to hydroxyapatite 
was not reported ensuring a predictable degradability (Tamimi et al., 2009).  
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Fig. 1. The microcrystalline structure of dicalcium phosphate dihydrate cement provide 
support for osteoblasts growth and proliferation that permits bone formation on and 
between calcium phosphate granulate.  
Recently, calcium phosphates are shown to be efficient as local drug and bioactives delivery 
system [Alkhraisat et al.,  2010).and the technology is now available to prepare custom-
made bone calcium phosphate based on patient’s CT scan data to fit in a bone defect 
[Klammert et al., 2010). These biomaterials are the corner-stone in the development of 3D-
porous scaffold in combination with organic components to resemble the inorganic-organic 
harmony of bone. Such scaffolds are designed to support the growth and differentiation of 
stem cells for their application in the emerging field of regenerative medicine. 
2.5 Bio glass  
Bioglass, also known as bioactive glass, is the commercial name for the first calcium 
substituted silicon oxide that was marketed as a bone regeneration material over 30 years 
ago. This material was developed by researchers working for the US army during the Vietnam 
War as a biomaterial for repairing bone loss in injured combat soldiers (Välimäki & Aro, 2006).  
In plain language bioglass is a glass similar to that in the windows of your house, but with a 
large portion of calcium in its chemical structure. It has a large surface area that is alkaline 
and highly reactive to serum ions. This feature enables it to interact with serum, allowing a 
very fast precipitation of hydroxyapatite on its surface once implanted in vivo. This 
phenomenon is called bioactivity, and is one of the unique characteristics of Bioglass that 
allows a quick integration to bone tissue. 
Bioglass is suitable for bone regeneration in dental implant surgery; moreover, it is purely 
synthetic therefore it does not present problems regarding transmission of infectious 
diseases. However, its granule format is difficult to handle due to the repulsive charges 
between the highly charged surfaces the granules. This renders its clinical handling more 
demanding than other biomaterials (Välimäki & Aro, 2006). 
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The critical component of bioglass is SiO2 which constitutes 45-60% of its weigth. The first 
bioglass developed for bone regeneration was based on 4 components: SiO2, Na2O, CaO and 
P2O5.However, this composition tend to crystallize, and was modified to a more stable glass 
composed of: Na2O-K2O-MgO-CaO-B2O3-P2O5-SiO2.In vivo experiments have shown that 
implantation of bioglass in bone defects causes an inhibition in bone formation during the 
early healing stages, but it eventually doubles the amount of bone formed when no 
biomaterial is used. 
Moreover, bioglass experiences sever resorption during the first 2 weeks after implantation. 
However, beyond this point its resorption rate is stabilizes. 
Upon implantation, the smaller ions present in bioglass (i.e. Na+ and K+) tend to leach to the 
extracellular fluids. This results in a rich Si layer coating the biomaterial. Ca2+ and PO43- ions 
from the body fluids then react and precipitate on the Si rich layer, forming a thin coat of 
hydroxyapatite. The calcium phosphate layer adsorbs proteins. And these extracellular 
properties attract macrophages stem cells and osteoprogenitor cells (Välimäki & Aro, 2006). 
Bioactive glass can be used in form of granules or as preformed cones designed for placement 
into fresh sockets to maintain the alveolar ridge (Stanley et al., 1997). It has shown clinical 
success in vertical bone augmentation procedures, in regeneration intra-bony defects and in 
the preservation of alveolar sockets (Gatti et al., 2006) .However, even though it is resorbable 
and promotes bone formation, its bone regeneration capacity in maxillofacial surgery has been 
shown to be lower than Calcium phosphate biomaterials (Santos et al., 2010). 
3. Surgical procedures that require the use of bone substitutes  
3.1 Sinus lift   
Bone augmentation in sinus lifting procedures requires the use of bone regeneration 
biomaterials that would enable bone formation within the maxillary sinus. Ideally besides 
good osteoconductive properties, biomaterials used for sinus lifting should be easy to 
handle, and have a limited in vivo resorption. Underneath we discuss the main bone 
substitutes that have been employed in sinus lift bone augmentation procedures 
Autograft: The use of bone autografts are recommended when treating large pneumatized 
sinuses and a short treatment period is required. The healing period in such situations is 3-4 
months shorter than when other bone substitutes are used (7-9 months). Also the use of 
autografts is an option when patients reject the use of allograft or bovine bone. Several 
studies have reported high rate of success using autografts from either endochondral or 
intramembranous origin. (Daelemans et al., 1997). Intramembranous bone has been shown 
to resorb less readily than endochondral bone (Hardesty et al., 1990).  Despite the excellent 
clinical results obtained with autografts,  a high degree of morbidity has been reported in 
such procedures. In order to diminish the morbidity and also the high resorption rate  of 
autografts,  many clinicians use autografts in combination with other bone substitutes in 
different proportions, and obtaining promising results.  
Autografts combined with ABB: Studies evaluating the use of bone autografts in combination 
with ABB, have shown great results in terms of percentage of newly formed bone in the 
sinus and subsequent implant success rate. Bone formation is higher when a major 
percentage of autograft  is added (48%) and significantly lower amounts of vital bone forms 
when autograft is used in minimal propoprtions. Froum et al. observed a statistically 
significant increase in vital bone formation when as little as 20% autologous bone was 
added to ABB compared with ABB alone. Nevertheless, a high percentage of bone volume 
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formation within the sinus is not a crucial parameter regarding the subsequent success rate 
of the dental implants. Indeed, bone volumes as low as  24% have shown to be sufficient for 
successful osteointegration of dental implants placed in augmented maxillay sinuses  
(Esposito et al., 2010).  
 
Vital bone formation with different types of graft in sinus augmentation 
Authors ABB:Autograft Healing time (months) Vital bone (%) 
Hallman et al 2002 100 Autograft 6-9 37 
John et al 2004 100 Autograft 3-8 53 
Mish & Krauser 2003 20:80 4-9 48 
Mish & Krauser 2003 40:60 4-9 36 
Mish & Krauser 2003 60:40 4-9 38 
Galindo et al 2010 80:20 6-9 46 
Hallman et al 2002 80:20 6-9 41 
Froum et al 2008 100 ABB 6 22 
Hallman et al 2002 100 ABB 6-9 39 
John et al 2004 100 ABB 3-8 29 
Table 4. Overview of different composite graft material  in sinus lift technique 
Allografts: Despite the risk of disease transmission associated with its use, approximately 
350.00 to 400.000 bone allografts procedures are performed in the United States, Out of 
which  100.000 are dental related. The use of  Allografts in sinus augmentation procedures 
has shown high success rates.  (Avila et al., 2010). The percentage of bone volume obtained 
with FDBA in sinus lifting procedures is 23%. Moreover, the success rate of implants placed 
in the maxillary sinuses following bone augmentation with solely applied allograft has been   
shown to be a 97.7% in three years follow up (Minichetti et al., 2008). On the other hand, 
Peleg et al reported a 100% success rate over 160 implants placed in 63 grafted sinuses using 
as graft material autogenous graft harvested from symphysis with DFDBA combined in 1:1 
ratio after a 4 year follow up (Peleg et al., 1999). 
DFDBA was compared with autograft in sinus augmentation procedures; DFDBA showed 
29% of new bone formation compared to a 40%  achieved with autograft (Kao 11). Froum 
also studies the differences between FDBA and ABB, observing a high vital bone formation 
(28%) in FDBA grafted sinuses compared to a 12% in ABB grafted ones’. (Froum et al., 2006). 
No differences have been observed between DFDBA and FDBA in terms of percentage of 
vital bone formation in the maxillary sinus.  
Anorganic bovine bone (ABB): ABB  is a biocompatible and osteoconductive anorganic bovine 
bone (ABB), that provides an ideal scaffold for new bone formation (Hammerle et al., 1998, 
Piatelli et al., 1999). It has been extensively used in maxillary sinus floor augmentation 
(Valentini et al., 2003, Wallace et al., 2005) with high clinical success rates (Carmagnola et al., 
2003). Comparative studies by Hallman et al and Valentini and Abensur observed higher 
survival rates for implants placed in sinuses grafted with 100% ABB compared with sinuses 
grafted with 100% autograft (Hallman., 2002, Valentini., 2003). Also Froum reports higher 
implant survival rate in sinuses grafted with ABB alone than those grafted with a composite 
of ABB+DFDBA (Froum et al., 2006).  In a recent study Torres et al observed a 97% implant 
success rate in 286 implants placed in 144 sinuses grafted with ABB alone or ABB+PRP.  
Overall, 96.2% of ABB and 98.6% of ABB+PRP implant success was obtained during the 
monitoring period and differences were not found between sites grafted with and without 
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PRP in the 87 patients studied. (Torres et al., 2009).  Regarding vital bone formation 
achieved with ABB in maxillary sinuses, Scarano et al compared ABB to autograft bone in 
maxillary sinus augmentation procedures. In this study, 6 months after the initial 
intervention, ABB resulted in 39% new bone formation compared to 40% with autograft. 
Although the results of new bone generation were very similar, 31% of the grafted Bio-Oss 
was still present at the graft site compared to only 18% of autograft (Scarano et al., 2006).(Fig 2) 
 
 
Fig. 2. Slow resorption of ABB particles could be observed after 24 months of implant´s 
placement. Blue arrow shows remanent ABB graft. Yellow arrow shows residual host bone 
 
 
Fig. 3. Bilateral sinus augmentation performed with ABB alone as graft material. 
Synthetic calcium phosphate such as ┚-TCP ceramic granules have also been used in sinus 
augmentation techniques with high rate of implant success. In a comparative study,  
Simunek et al showed that a higher proportion of the new vital bone was achieved with 
ABB (34.2%) compared to  ┚-TCP (21.4%). (Simunek et al. 2008) 
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However Szabó et al  in another comparative study between ┚-TCP ceramic granules versus 
autograft observe that  vital bone areas were 36% and 38%, respectively.(Szabó et al. 2005) 
Rapidly  resorbable biomaterials are not recommended for sinus lift procedures since the 
maxillary sinus is a non functional site for bone to form, and in the absence of mechanical 
load any bone augmentation achieved is likely to be lost if the scaffold provided by the 
biomaterial resorbs. For these reasons the most suitable biomaterials for sinus lifting 
procedures are osteoconductive biomaterials with limited or non resorption properties such 
as granules of ABB, ┚-TCP, hydroxyapatite, biphasic calcium phosphate and Bioglass. 
In a recent systematic review performed by Esposito, it was concluded that ABB and ┚-TCP 
might be as effective as bone autografts for augmenting atrophic maxillary sinuses. 
Therefore these biomaterials might be used as replacement for autogenous bone grafting 
(Esposito et al. 2010).(Fig 3) 
3.2 Alevolar ridge augmentation 
3.2.1 Onlay bone grafts  
Onlay bone grafts 
Onlay bone grafting is the most predictable technique available for bone augmentation of 
the alveolar ridge. This procedure is used to augment bone before or at the time of implant 
placement to ensure proper implant osteointegration (Rocchietta et al. 2008)  
Onlay bone grafting is achieve by fixing a  biomaterial in the shape of a block directly onto 
the bone surface of the  alveolar ridge, and covered with the periosteum and oral mucosa. 
This procedure requires a biomaterial strong enough to bear direct occlusal forces and allow 
screw fixation. Besides, the biomaterial should also be bioresorbable and osteconductive.  
Currently the best available biomaterial for onlay bone grafting is the autologous bone graft. 
Autologus onlay bone grafts can be harvested from extra-oral or intra-oral bones (Rocchietta 
et al., 2008).Onlay grafts of autologous bone can resorb once implanted, limiting the amount 
of bone volume available for dental implant stabilization. In this sence, intra-oral grafts are 
always preferred, since they tend resorb less than extra-oral bone grafts after implantation 
(Rocchietta et al., 2008).  
The limited amount of autlogous bone available for grafting alongside the morbidity 
associated to the donor site has driven the need for developing alternative materials. 
Accordingly, alloplastic, allogenic and xenogenic onlay blocks have been recently developed 
and tested showing promising results. Several animals studies have shown that blocks made 
of either allogenic materials, hydroxyapatite, tricalcium phosphate or monetite are capable 
of achieving vertical bone augmentation in onlay bone graft procedures (Tamura et al., 2007, 
Tamimi et al .,2009, Fujita et al., 2003, Hetherington et al., 1996).Moreover, clinical studies 
have confirmed the great potential of allogenic bone blocks as biomaterials for onlay bone 
augmentation (Waasdorp et al., 2010) 
In order to achieve succes with an onlay bone graft procedure, the onlay blocks have to be 
firmly secured to the recipient bone surfaces with osteosynthesis screws. These screws used 
for onlay bone grafts are made of either titanium or of a resorbable biomaterial. Titanium 
screws are stronger, but they require a second surgery for removal before implant 
placement, sometimes resulting in screw fracture during removal. Resorbable screws are 
weaker but do not need to be removed. Both screw systems offer predictable clinical results 
(Quereshy et al., 2010). 
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Usually, onlay bone grafts are placed without the use of barrier membranes. This fact 
renders the onlay sensitive to masticatory forces, and requires the  patients not to wear any 
removable prosthesis after the regeneration procedure for a period of at least 2 months 
(Rocchietta et al., 2008).For this reason, recent studies have tested the benefits of covering  
onlay bone grafts with resorbable membranes. This novel procedure, been shown to be 
beneficial in preventing grafts resorption due to masticatory forces (Rocchietta et al., 
2008).(Fig 4,5) 
 
 
Fig. 4. Slightly resorption with autogenous intraoral bone in the most coronal part of the 
graft is observed in a patient where no membrane was used. 
 
Fig. 5. Remodelling of allograft has been produced after 4 month. Grafts of right side of the 
patient were covered by a membrane conserving all the volume, while left side graft´s were 
not covered observing more resorption in this side. 
3.2.2 Guided bone regeneration & titanium mesh 
Guided bone regeneration (GBR) and Titanium mesh technique (Ti-mesh) provide bone 
augmentation of the alveolar ridge and create the conditions needed for better aesthetic and 
higher rate of dental implants success. In order to achieve high rates of success in GBR and 
Ti-mesh procedures,  there are three major issues that need to be addressed: coagulum 
maintenance, free tension flap closure and an adequate biomaterial selection.  
In the treatment of large defects autografts are considered the gold standard, since they have 
osteoinductive, osteoconductive,  osteogenic properties and no risk of immunologic 
rejection. In view of mechanical properties, cancellous bone grafts still clearly surpassed by 
ABB, coral, or synthetic bone substitute. However,  it provides a high amount of vital stem 
cells and proteins, such as BMPs, that result in osteogenesis and osteoinduction, therefore  
GBR with particulated autografts is a safe and predictable treatment (Urban et al., 2009). 
Autografts combined with ABB have been used with success in GBR (Table 5). However in 
the last years different studies have shown that even allografts alone offer reliable results in 
www.intechopen.com
 
Implant Dentistry – The Most Promising Discipline of Dentistry 
 
104 
large defects, with less cost on the patient. In a study performed by Dahlin they conclude 
that reconstruction of atrophic maxillae with DFDB using the GBR technique can be 
performed with an equal success as iliac crest autografts   (Dahlin., 2010) 
Allografts, alloplasts or xenografts are considered appropriate candidates for small defects 
(Fig 6, 7). Allograft bone, is the most popular alternative to autogenous bone. It offers the 
substantial advantage of allowing the patient to avoid a second surgical procedure, with the 
attendant risks of pain, complications, and morbidity. Available in various shapes and sizes, 
allograft bone also has fewer supply restrictions than autograft material. Synthetic bone 
graft materials (alloplasts) constitute a third category of widely used bone-grafting 
materials, including such non-human, artificially produced materials as calcium sulfate, 
calcium phosphate, hydroxyapatite, and bioactive glass. Their advantages consist on their 
abundant supply, long shelf lives, and lack of potential disease transmission. Their capacity 
to predictably regenerate bone has not yet been demonstrated consistently. Xenografts 
constitute the final category of bone-grafting materials in common use. Derived from animal 
sources, xenografts have been developed largely in response to the donor site complications 
associated with autografts, as well as the limited supplies of both autogenous and allograft 
material. Porous bovine-derived material is by far the most common variety of xenograft in 
use today. Such material has been demonstrated to be highly biocompatible. Histologic 
analysis has found bovine bone particles to be well incorporated within newly regenerated 
grafted bone and a high degree of osseoconductivity 
 
 
Fig. 6. A. Ti mesh augmentation procedure in upper maxilla using ABB alone as graft 
material. B. PRP covering Ti mesh in order to enhance soft tissue healing. C. Soft tissue 
healing after six month of surgery. D,E, F. TC scan images showing horizontal (5 mm) and 
vertical (3 mm) bone augmentation achieved.G,H,I. Implant´s placement  and prosthesis 
evaluation radiography. I. Image of prosthesis rehabilitation. 
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Fig. 7. ABB particles surrounded by newly formed bone in a Ti-mesh bone augmentation 
procedure where ABB alone was used as graft material. 
 
Type of Graft 
(%) 
ABW 
(mm) 
ABH 
(mm) 
Survival  
(%) 
Success  
(%) 
References 
AB (100)  ID ID  ID ID Von Arx et al 1996 
AB (100)  5.65 ID  ID 100 Malchiodi et al 1998 
AB (100) *  ID 5  ID ID Rocuzzo et al 2004 
AB (100) *  ID 4.8  100 100 Rocuzzo et al 2007 
AB/ABB (50/50)  ID ID  98.3 ID Maiorana et al 2001 
AB/ABB (70/30)  4.16 3.71  100 100 Pieri et al 2008 
AB/ABB (70/30)  ID ID  100 100 Corinaldesi et al 2007 
AB/ABB (ID)  3.71 2.86  ID ID Profusaefs & Lozana 2006 
ABB (100)  ID 5.2 100 ID Artzi et al 2003 
Pts: patients; BAP: bone augmentation procedures; ABW: average bone width gained;  ABH: average bone height 
gained; AB: autologous bone; ID: insufficient data;*: block grafts. 
Table 5. Summary of clinical studies reporting the amount bone gained, type of graft and 
complications rate using the Ti-mesh technique. (Modified from Torres et al 2010) 
3.3 Treating fenestrations and dehiscence   
Particulate autogenous bone, anorganic bovine bone and FDBA have been proposed for 
treatment such defects in combination with GBR technique. 
4. Summary  
Since the introduction of dental implants, bone grafting has become an important procedure 
required for the treatment of patients with limited bone availability.  Bone autograft, alone 
or together with other bone substitutes, has been the biomaterial of choice for clinicians 
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worldwide. However different xenogenic, allogenic and synthetic biomaterials have shown 
promising results in many bone augmentation procedures.  
The bone substitute needed for each bone regeneration procedure must be selected based on 
the individual´s characteristics, and the surgical procedure it self.  Factors such as the 
osteogenic potential of the host residual bone, systemic health of patients, and morphology 
of the defects, will delimit the ideal bone substitute for each situation. For example in sinus 
augmentation, allografts, xenografs and synthetic calcium phosphates have been used as 
alternative to autografts with high rate of implants success and survival. On the other hand, 
when major alveolar ridge augmentations are required autograft  onlay block are the most 
predictable biomaterials, although autograft granules mixed in different proportions with 
ABB in GBR procedures have also a high rate of success.   
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